• 1. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

Introduction to 1-Bromo-2,5-dimethyl-3-nitrobenzene (CAS No. 52415-03-9)

1-Bromo-2,5-dimethyl-3-nitrobenzene, identified by its Chemical Abstracts Service (CAS) number 52415-03-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and materials chemistry. This aromatic heterocyclic compound features a bromine substituent and nitro groups at specific positions on a dimethylated benzene ring, making it a versatile intermediate in synthetic chemistry. Its unique structural properties have positioned it as a valuable building block for the development of novel compounds with potential applications in medicinal chemistry, agrochemicals, and advanced material synthesis.

The molecular structure of 1-Bromo-2,5-dimethyl-3-nitrobenzene consists of a benzene core substituted with two methyl groups at the 2- and 5-positions, a bromine atom at the 1-position, and a nitro group at the 3-position. This arrangement imparts distinct electronic and steric characteristics to the molecule, influencing its reactivity and utility in chemical transformations. The presence of both bromine and nitro functional groups makes it particularly interesting for cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex organic molecules.

In recent years, the demand for 1-Bromo-2,5-dimethyl-3-nitrobenzene has surged due to its role in synthesizing biologically active compounds. Researchers have leveraged its reactive sites to develop novel pharmacophores targeting various therapeutic areas. For instance, studies have explored its use in generating derivatives with antimicrobial and anti-inflammatory properties. The nitro group can be reduced to an amine, enabling further functionalization into more complex structures, while the bromine atom serves as an excellent handle for introducing additional substituents through palladium-catalyzed reactions.

One of the most compelling applications of 1-Bromo-2,5-dimethyl-3-nitrobenzene lies in its utility as a precursor for advanced materials. The compound’s ability to undergo selective functionalization has been exploited in the design of liquid crystals and organic semiconductors. These materials are critical components in electronic displays, solar cells, and sensors, where precise molecular architecture is essential for optimal performance. The dimethyl groups at the 2- and 5-positions contribute to steric hindrance, influencing packing arrangements in solid-state materials and thereby affecting their physical properties.

Recent advancements in synthetic methodologies have further enhanced the appeal of 1-Bromo-2,5-dimethyl-3-nitrobenzene. Techniques such as flow chemistry have enabled more efficient and scalable production processes for this compound. Additionally, green chemistry principles have been applied to minimize waste and improve sustainability in its synthesis. These innovations align with global efforts to promote environmentally responsible chemical manufacturing while maintaining high yields and purity standards.

The pharmaceutical industry has been particularly keen on exploring 1-Bromo-2,5-dimethyl-3-nitrobenzene for drug discovery applications. Its structural motif is reminiscent of several known bioactive molecules, suggesting potential therapeutic relevance. Researchers are investigating its derivatives as intermediates for kinase inhibitors, which play a crucial role in treating cancers and inflammatory diseases. The nitro group’s ability to modulate electronic properties also makes it valuable for designing molecules with enhanced binding affinity to biological targets.

In conclusion,1-Bromo-2,5-dimethyl-3-nitrobenzene (CAS No. 52415-03-9) represents a cornerstone compound in modern synthetic chemistry. Its unique structural features enable diverse applications across pharmaceuticals, materials science, and agrochemicals. As research continues to uncover new methodologies for its synthesis and utilization,1-Bromo-2,5-dimethyl-3-nitrobenzene is poised to remain an indispensable tool for chemists seeking to innovate at the intersection of biology and advanced materials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)